ClinicalTrials.gg
Drug

Icatibant clinical trials

Also written Firazyr and HOE-140.

studies test it
23
open now
0
in phase 3
10
first study started
2004

How each study uses icatibant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
25 Aug 2011 · FIRAZYR · NDA 022150 (FDA, Drugs@FDA)
European Union
11 Jul 2008 · Firazyr · EMEA/H/C/000899 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Icatibant
16
Brand name, Firazyr®
3
bradykinin receptor antagonist (HOE-140)
2

Brand

Firazyr
8

Development codes

HOE-140
4
TAK-667
1

Studies by the year they started

23 studies that test it; most in 2009 (4)

Studies that test icatibant, by start year
YearStudies
20041
20051
20062
20071
20094
20112
20121
20131
20141
20151
20172
20201
20213
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
7
Phase 3
10
Phase 4
3
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 12

Shire (8) · Vanderbilt University Medical Center (4) · Vanderbilt University (2) · University of Edinburgh (2) · QuantumLeap Healthcare Collaborative (1) · Nang Kuang Pharmaceutical Co., Ltd. (1) · GCS Ramsay Santé pour l'Enseignement et la Recherche (1) · Sebastian Videla (1)

Often tested with

Tested in the same studies.

Remdesivir (1) · Imatinib (1) · Dexamethasone (1) · Cenicriviroc (1) · Apremilast (1) · Dornase alfa (1) · Celecoxib (1) · Famotidine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test icatibant, phase 3 first.

Studies

Open first, then newest update. How each study uses icatibant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test icatibant →

Given beside what is tested · 1 — icatibant is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with icatibant

Codes

What other systems call icatibant · ClinicalTrials.gg INT003531

  • MeSH (NLM) C065679icatibantConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7PG89G35Q7ICATIBANTConfirmed FDA, NLM, Wikidata
  • RxNorm 1148138Confirmed FDA, Wikidata
  • Wikidata Q902379icatibantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C98883IcatibantOne source FDA
  • DrugBank DB06196One source Wikidata

Also registered as icatibant acetate (UNII 325O8467XK · RxNorm 1294605).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.